Concepts (200)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart-Assist Devices | 28 | 2022 | 1026 | 2.600 |
Why?
|
| Heart Transplantation | 13 | 2022 | 854 | 1.340 |
Why?
|
| Heart, Artificial | 6 | 2018 | 69 | 1.300 |
Why?
|
| Heart Failure | 18 | 2022 | 2131 | 1.260 |
Why?
|
| Ventricular Dysfunction, Left | 3 | 2019 | 360 | 0.750 |
Why?
|
| Models, Cardiovascular | 3 | 2018 | 180 | 0.720 |
Why?
|
| Cardiomyopathies | 2 | 2019 | 478 | 0.530 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2014 | 61 | 0.450 |
Why?
|
| Cardiomyopathy, Dilated | 2 | 2005 | 214 | 0.380 |
Why?
|
| Thrombosis | 3 | 2014 | 518 | 0.380 |
Why?
|
| Assisted Circulation | 2 | 2014 | 34 | 0.360 |
Why?
|
| Heart Ventricles | 4 | 2017 | 763 | 0.330 |
Why?
|
| Receptors, Adrenergic, beta | 2 | 2008 | 58 | 0.320 |
Why?
|
| Prosthesis Design | 6 | 2019 | 675 | 0.320 |
Why?
|
| Pulsatile Flow | 4 | 2016 | 133 | 0.290 |
Why?
|
| Myocardium | 4 | 2018 | 986 | 0.290 |
Why?
|
| Plasma Exchange | 1 | 2008 | 84 | 0.280 |
Why?
|
| Pulse | 1 | 2006 | 31 | 0.270 |
Why?
|
| Atrial Natriuretic Factor | 2 | 2005 | 52 | 0.260 |
Why?
|
| Preoperative Care | 1 | 2008 | 348 | 0.250 |
Why?
|
| Nitric Oxide Synthase | 1 | 2005 | 187 | 0.230 |
Why?
|
| Transplantation, Heterotopic | 2 | 2014 | 29 | 0.230 |
Why?
|
| Middle Aged | 21 | 2019 | 26089 | 0.220 |
Why?
|
| Treatment Outcome | 13 | 2022 | 12170 | 0.210 |
Why?
|
| Jehovah's Witnesses | 1 | 2023 | 15 | 0.210 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2010 | 1099 | 0.210 |
Why?
|
| Aorta | 1 | 2006 | 542 | 0.210 |
Why?
|
| Myocardial Ischemia | 2 | 2005 | 332 | 0.200 |
Why?
|
| Bioprosthesis | 3 | 2018 | 111 | 0.200 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2005 | 667 | 0.200 |
Why?
|
| Aged | 16 | 2019 | 19196 | 0.200 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2002 | 168 | 0.180 |
Why?
|
| Male | 27 | 2022 | 60335 | 0.180 |
Why?
|
| Humans | 35 | 2023 | 123265 | 0.170 |
Why?
|
| Survival Rate | 4 | 2019 | 2002 | 0.170 |
Why?
|
| Anemia | 1 | 2023 | 341 | 0.160 |
Why?
|
| Intra-Aortic Balloon Pumping | 1 | 2019 | 42 | 0.160 |
Why?
|
| Bioartificial Organs | 1 | 2018 | 11 | 0.160 |
Why?
|
| Adult | 21 | 2022 | 29100 | 0.160 |
Why?
|
| Hemodynamics | 4 | 2016 | 843 | 0.150 |
Why?
|
| Materials Testing | 1 | 2018 | 73 | 0.150 |
Why?
|
| Tissue Scaffolds | 1 | 2018 | 74 | 0.150 |
Why?
|
| Female | 23 | 2022 | 65619 | 0.140 |
Why?
|
| Renal Replacement Therapy | 1 | 2019 | 141 | 0.140 |
Why?
|
| Extracellular Matrix | 1 | 2018 | 232 | 0.140 |
Why?
|
| Equipment Design | 4 | 2016 | 604 | 0.140 |
Why?
|
| Tissue Engineering | 1 | 2018 | 176 | 0.140 |
Why?
|
| Prosthesis Implantation | 1 | 2017 | 143 | 0.130 |
Why?
|
| Hemorheology | 1 | 2015 | 28 | 0.120 |
Why?
|
| Cattle | 4 | 2018 | 562 | 0.120 |
Why?
|
| Capillary Permeability | 1 | 2015 | 77 | 0.120 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2023 | 1201 | 0.120 |
Why?
|
| SKP Cullin F-Box Protein Ligases | 1 | 2014 | 19 | 0.110 |
Why?
|
| Retrospective Studies | 9 | 2022 | 16069 | 0.110 |
Why?
|
| Microscopy, Fluorescence | 2 | 2005 | 330 | 0.110 |
Why?
|
| Time Factors | 5 | 2010 | 6223 | 0.110 |
Why?
|
| Cardiomegaly | 1 | 2014 | 134 | 0.110 |
Why?
|
| Myocytes, Cardiac | 2 | 2018 | 619 | 0.110 |
Why?
|
| Hemorrhage | 2 | 2013 | 458 | 0.100 |
Why?
|
| Recovery of Function | 2 | 2012 | 437 | 0.100 |
Why?
|
| Thromboembolism | 2 | 2010 | 84 | 0.100 |
Why?
|
| Cohort Studies | 3 | 2013 | 4701 | 0.100 |
Why?
|
| Ventricular Function, Left | 2 | 2012 | 496 | 0.090 |
Why?
|
| Muscle Proteins | 1 | 2014 | 418 | 0.090 |
Why?
|
| Heart Defects, Congenital | 1 | 2022 | 1803 | 0.090 |
Why?
|
| Stroke | 3 | 2013 | 958 | 0.090 |
Why?
|
| Miniaturization | 1 | 2009 | 27 | 0.080 |
Why?
|
| Transposition of Great Vessels | 1 | 2010 | 131 | 0.080 |
Why?
|
| Canada | 1 | 2010 | 293 | 0.080 |
Why?
|
| Young Adult | 6 | 2013 | 8867 | 0.080 |
Why?
|
| Long-Term Care | 1 | 2009 | 70 | 0.080 |
Why?
|
| Aged, 80 and over | 5 | 2013 | 6392 | 0.080 |
Why?
|
| Survival Analysis | 2 | 2010 | 1473 | 0.080 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 586 | 0.080 |
Why?
|
| Receptors, Adrenergic, alpha | 1 | 2008 | 8 | 0.080 |
Why?
|
| Thoracotomy | 1 | 2009 | 108 | 0.080 |
Why?
|
| Bleeding Time | 1 | 2008 | 8 | 0.080 |
Why?
|
| Shock, Cardiogenic | 1 | 2010 | 190 | 0.080 |
Why?
|
| Prothrombin Time | 1 | 2008 | 36 | 0.080 |
Why?
|
| Partial Thromboplastin Time | 1 | 2008 | 45 | 0.070 |
Why?
|
| United States | 5 | 2022 | 10654 | 0.070 |
Why?
|
| Bilirubin | 1 | 2008 | 121 | 0.070 |
Why?
|
| Postoperative Hemorrhage | 1 | 2008 | 87 | 0.070 |
Why?
|
| Antigens, CD | 2 | 2015 | 420 | 0.070 |
Why?
|
| Disease-Free Survival | 1 | 2009 | 858 | 0.070 |
Why?
|
| Cause of Death | 2 | 2009 | 463 | 0.070 |
Why?
|
| Hemoglobins | 1 | 2008 | 303 | 0.070 |
Why?
|
| Creatinine | 1 | 2008 | 382 | 0.070 |
Why?
|
| Postoperative Complications | 2 | 2017 | 3020 | 0.060 |
Why?
|
| Adolescent | 8 | 2013 | 19127 | 0.060 |
Why?
|
| Sheep | 1 | 2006 | 209 | 0.060 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2008 | 344 | 0.060 |
Why?
|
| Blood Transfusion | 2 | 2023 | 304 | 0.060 |
Why?
|
| Blotting, Western | 2 | 2005 | 1102 | 0.060 |
Why?
|
| Brachiocephalic Trunk | 1 | 2005 | 35 | 0.060 |
Why?
|
| Electrophoresis | 1 | 2005 | 47 | 0.060 |
Why?
|
| Hemolysis | 2 | 2018 | 105 | 0.060 |
Why?
|
| Blood Flow Velocity | 1 | 2006 | 449 | 0.060 |
Why?
|
| Anticoagulants | 1 | 2009 | 580 | 0.060 |
Why?
|
| Proportional Hazards Models | 3 | 2017 | 1304 | 0.060 |
Why?
|
| Caveolins | 1 | 2003 | 15 | 0.050 |
Why?
|
| Heart | 2 | 2014 | 723 | 0.050 |
Why?
|
| Device Removal | 1 | 2005 | 222 | 0.050 |
Why?
|
| Quality of Life | 4 | 2022 | 1933 | 0.050 |
Why?
|
| Animals | 6 | 2018 | 33859 | 0.050 |
Why?
|
| Heart Valve Prosthesis | 2 | 2003 | 293 | 0.050 |
Why?
|
| Genes, erbB-2 | 1 | 2002 | 37 | 0.050 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2003 | 85 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2022 | 263 | 0.050 |
Why?
|
| Biopsy | 1 | 2005 | 1236 | 0.050 |
Why?
|
| ErbB Receptors | 1 | 2002 | 283 | 0.040 |
Why?
|
| Video Recording | 1 | 2002 | 182 | 0.040 |
Why?
|
| Prosthesis Failure | 2 | 2012 | 159 | 0.040 |
Why?
|
| Severity of Illness Index | 2 | 2005 | 2854 | 0.040 |
Why?
|
| Membrane Glycoproteins | 1 | 2002 | 413 | 0.040 |
Why?
|
| Outpatients | 2 | 2013 | 254 | 0.040 |
Why?
|
| Aortic Valve | 1 | 2003 | 437 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2023 | 1385 | 0.040 |
Why?
|
| Internet | 1 | 2002 | 378 | 0.040 |
Why?
|
| Coronary Artery Disease | 1 | 2005 | 750 | 0.040 |
Why?
|
| Heart Diseases | 1 | 2003 | 481 | 0.040 |
Why?
|
| Platelet Activation | 1 | 2018 | 70 | 0.040 |
Why?
|
| Cell Adhesion | 1 | 2018 | 318 | 0.040 |
Why?
|
| Gene Expression | 1 | 2002 | 1566 | 0.040 |
Why?
|
| Benchmarking | 1 | 2018 | 132 | 0.040 |
Why?
|
| von Willebrand Factor | 1 | 2018 | 196 | 0.030 |
Why?
|
| Pressure | 1 | 2016 | 129 | 0.030 |
Why?
|
| Microcirculation | 1 | 2016 | 93 | 0.030 |
Why?
|
| Biomarkers | 1 | 2005 | 2953 | 0.030 |
Why?
|
| Adherens Junctions | 1 | 2015 | 12 | 0.030 |
Why?
|
| Swine | 1 | 2018 | 1167 | 0.030 |
Why?
|
| Microvessels | 1 | 2015 | 56 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2018 | 529 | 0.030 |
Why?
|
| Child | 4 | 2022 | 24256 | 0.030 |
Why?
|
| Cadherins | 1 | 2015 | 164 | 0.030 |
Why?
|
| Edema | 1 | 2015 | 136 | 0.030 |
Why?
|
| Blood Volume | 1 | 2014 | 80 | 0.030 |
Why?
|
| NFATC Transcription Factors | 1 | 2014 | 42 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2014 | 101 | 0.030 |
Why?
|
| Vascular Resistance | 1 | 2014 | 189 | 0.030 |
Why?
|
| Preoperative Period | 1 | 2013 | 82 | 0.030 |
Why?
|
| Calcineurin | 1 | 2014 | 100 | 0.030 |
Why?
|
| Feedback | 1 | 2014 | 162 | 0.030 |
Why?
|
| Proteolysis | 1 | 2014 | 163 | 0.030 |
Why?
|
| Ventricular Remodeling | 1 | 2014 | 174 | 0.030 |
Why?
|
| Retreatment | 1 | 2012 | 88 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 2015 | 516 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2014 | 632 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2022 | 6030 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2016 | 1326 | 0.020 |
Why?
|
| Follow-Up Studies | 3 | 2012 | 5056 | 0.020 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2010 | 114 | 0.020 |
Why?
|
| Actuarial Analysis | 1 | 2009 | 30 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2003 | 1289 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2010 | 355 | 0.020 |
Why?
|
| Software | 1 | 2014 | 675 | 0.020 |
Why?
|
| International Normalized Ratio | 1 | 2009 | 42 | 0.020 |
Why?
|
| Ventricular Function, Right | 1 | 2010 | 112 | 0.020 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2010 | 238 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2015 | 941 | 0.020 |
Why?
|
| Warfarin | 1 | 2009 | 118 | 0.020 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2009 | 210 | 0.020 |
Why?
|
| Aspirin | 1 | 2009 | 220 | 0.020 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2009 | 233 | 0.020 |
Why?
|
| Stroke Volume | 1 | 2009 | 446 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2008 | 229 | 0.020 |
Why?
|
| Registries | 1 | 2013 | 1398 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2009 | 1006 | 0.020 |
Why?
|
| Age Factors | 1 | 2013 | 2811 | 0.020 |
Why?
|
| Palliative Care | 1 | 2010 | 428 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2014 | 3727 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2010 | 1389 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 2526 | 0.020 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2005 | 127 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2005 | 279 | 0.010 |
Why?
|
| Probability | 1 | 2005 | 321 | 0.010 |
Why?
|
| Caveolin 2 | 1 | 2003 | 1 | 0.010 |
Why?
|
| Caveolin 3 | 1 | 2003 | 7 | 0.010 |
Why?
|
| Mitral Valve Stenosis | 1 | 1983 | 34 | 0.010 |
Why?
|
| Caveolin 1 | 1 | 2003 | 46 | 0.010 |
Why?
|
| CD36 Antigens | 1 | 2003 | 35 | 0.010 |
Why?
|
| Reference Values | 1 | 2005 | 701 | 0.010 |
Why?
|
| Waiting Lists | 1 | 2005 | 225 | 0.010 |
Why?
|
| Receptor, ErbB-4 | 1 | 2002 | 7 | 0.010 |
Why?
|
| Cytokine Receptor gp130 | 1 | 2002 | 13 | 0.010 |
Why?
|
| Decision Support Techniques | 1 | 2005 | 280 | 0.010 |
Why?
|
| Calcinosis | 1 | 1983 | 170 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2003 | 401 | 0.010 |
Why?
|
| Coronary Artery Bypass | 1 | 2005 | 490 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2014 | 4501 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2005 | 2019 | 0.010 |
Why?
|
| Risk Factors | 1 | 2013 | 10035 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2003 | 1687 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2002 | 862 | 0.010 |
Why?
|
| Aortic Valve Stenosis | 1 | 1983 | 332 | 0.010 |
Why?
|
| Critical Care | 1 | 2005 | 648 | 0.010 |
Why?
|
| Mice | 1 | 2014 | 17562 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2002 | 1703 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2003 | 2816 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2005 | 3336 | 0.010 |
Why?
|